Navigation Links
Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research

ALBANY, New York, March 13, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research ( "Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the global peptide therapeutics market was valued at USD 14.1 billion in 2011 and is estimated to reach a market worth USD 25.4 billion in 2018 at a CAGR of 8.7% from 2012 to 2018.

Browse the full report at

The growth of the market is driven by factors such as rising incidences of cardiovascular diseases, metabolic diseases and technological enhancement in peptide synthesis. The Asian region offers future growth prospects to the peptide industry owing to vast unmet medical needs and rising disposable income of patients.

Amongst the application market, the cancer peptide segment accounted for the largest share of approximately 21% and is expected to grow at a healthy CAGR during the forecast period. The neuropeptides application segment is anticipated to grow at a CAGR of 9.4% from 2012 to 2018 due to the rise in number of neurological disorders such as Alzheimer's and Parkinson's disease.

Related & Recently Published Reports by Transparency Market Research

The parenteral route of administration of peptides accounted for the largest share of around 86% in year 2011, in terms of routes of administration; however other routes of administration like oral, pulmonary, nasal and intradermal are also being tested and are estimated to experience healthy growth rate during the forecast period.

Technological enhancement with introduction of hybrid technology along with solid phase peptide syntheses (SPPS) is expected to enhance the growth of peptide therapeutics. The hybrid technology segment which provides the best of both solid and liquid syntheses is now being adopted by major players and hence this market is expected to see the highest growth of 12.1% from 2012 to 2018.

Related & Recently Published Reports by Transparency Market Research

The North American peptide therapeutics market held majority of the market share of approximately 40% in 2011 owing to its developed economy. However, due to rise in cost containment and budgetary cuts in North America, emerging countries such as India, China and other Latin American countries is expected to see a healthy growth in the study period.

Some of the key market players are Eli Lilly, Roche, Amylin, Novo-Nordisk, Ipsen and others. The contract manufacturing organization (CMO) industry includes major players such as Bachem, Polypeptide Group, Lonza, Peptisyntha and others.

  • Peptide Therapeutics Market, by Applications







    Gastro Intestinal





  • Peptide Therapeutics Market, by Route of Administration






  • Peptide Therapeutics Market, by Types



  • Peptide Therapeutics Market, by API Peptide


    CMO (Contract Manufacturing Organization)

  • Peptide Therapeutics by technology

    Liquid Phase Peptide Synthesis (LPPS)

    Solid Phase Peptide Synthesis (SPPS)


  • Peptide Therapeutics Market, by Geography

    North America




Browse all Pharmaceutical Market Research Reports @

Upcoming Reports in Pharmaceutical Market

Metabolomics Market

Medical Tourism Market

Monoclonal Antibodies Market

Cell Based Assays Market

Nutraceuticals Market

Drug Discovery Technologies Market

Sample Preparation In Genomics

Antibody Drugs Market

Osteoporosis Market

Treatments for Neurodegenerative Disorders

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

SOURCE Transparency Market Research
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Waters Unveils Industrys First Integrated LC/MS Platform for Proteins, Peptides, and Glycans Analysis at WCBP 2013
2. Small peptide ameliorates autoimmune skin blistering disease in mice
3. US Patent awarded for using Metal Peptides to Help Diminish Skin Imperfections
4. Strategic Analysis of the Collagen Peptide Market in the United States
5. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
6. Pain Therapeutics - Drugs, Markets and Companies - 2013 Report
7. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
8. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
9. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
10. United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
11. Society for Brain Mapping and Therapeutics endorse President Obamas support for Human Brain Mapping research; nominating him for prestigious Pioneer in Healthcare Policy Award
Post Your Comments:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology:
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
Breaking Biology News(10 mins):